These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2063 related items for PubMed ID: 15585605

  • 1. Toll-like receptors in innate immunity.
    Takeda K, Akira S.
    Int Immunol; 2005 Jan; 17(1):1-14. PubMed ID: 15585605
    [Abstract] [Full Text] [Related]

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 3. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K.
    J Endotoxin Res; 2005 Sep; 11(1):51-5. PubMed ID: 15826379
    [Abstract] [Full Text] [Related]

  • 4. Regulation of innate immune responses by Toll-like receptors.
    Takeda K, Akira S.
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [Abstract] [Full Text] [Related]

  • 5. [TIR domain--containing adaptors regulate TLR-mediated signaling pathways].
    Yamamoto M, Akira S.
    Nihon Rinsho; 2004 Dec; 62(12):2197-203. PubMed ID: 15597785
    [Abstract] [Full Text] [Related]

  • 6. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
    Dunne A, O'Neill LA.
    Sci STKE; 2003 Feb 25; 2003(171):re3. PubMed ID: 12606705
    [Abstract] [Full Text] [Related]

  • 7. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG, van der Graaf C, Van der Meer JW, Kullberg BJ.
    J Leukoc Biol; 2004 May 25; 75(5):749-55. PubMed ID: 15075354
    [Abstract] [Full Text] [Related]

  • 8. Pathogen recognition with Toll-like receptors.
    Kawai T, Akira S.
    Curr Opin Immunol; 2005 Aug 25; 17(4):338-44. PubMed ID: 15950447
    [Abstract] [Full Text] [Related]

  • 9. Toll-like receptor signaling pathways.
    Barton GM, Medzhitov R.
    Science; 2003 Jun 06; 300(5625):1524-5. PubMed ID: 12791976
    [Abstract] [Full Text] [Related]

  • 10. Bacterial modulation of mucosal innate immunity.
    Kelly D, Conway S.
    Mol Immunol; 2005 May 06; 42(8):895-901. PubMed ID: 15829279
    [Abstract] [Full Text] [Related]

  • 11. Primers on molecular pathways: lipopolysaccharide signaling - potential role in pancreatitis and pancreatic cancer.
    Del Pozo JL.
    Pancreatology; 2010 May 06; 10(2-3):114-8. PubMed ID: 20460943
    [Abstract] [Full Text] [Related]

  • 12. Signal integration following Toll-like receptor triggering.
    Dalpke A, Heeg K.
    Crit Rev Immunol; 2002 May 06; 22(3):217-50. PubMed ID: 12498384
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Toll-like receptors.
    Lien E, Ingalls RR.
    Crit Care Med; 2002 Jan 06; 30(1 Suppl):S1-11. PubMed ID: 11782555
    [Abstract] [Full Text] [Related]

  • 15. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
    Takesue Y, Ohge H, Kohyama M, Imamura Y, Murakami Y, Sueda T.
    Nihon Geka Gakkai Zasshi; 2003 Jul 06; 104(7):494-8. PubMed ID: 12884772
    [Abstract] [Full Text] [Related]

  • 16. TLR signaling.
    Kawai T, Akira S.
    Semin Immunol; 2007 Feb 06; 19(1):24-32. PubMed ID: 17275323
    [Abstract] [Full Text] [Related]

  • 17. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
    Hall C, Flores MV, Chien A, Davidson A, Crosier K, Crosier P.
    J Leukoc Biol; 2009 May 06; 85(5):751-65. PubMed ID: 19218482
    [Abstract] [Full Text] [Related]

  • 18. How we detect microbes and respond to them: the Toll-like receptors and their transducers.
    Beutler B, Hoebe K, Du X, Ulevitch RJ.
    J Leukoc Biol; 2003 Oct 06; 74(4):479-85. PubMed ID: 12960260
    [Abstract] [Full Text] [Related]

  • 19. [Receptors and signal proteins of the innate immune system as new targets in sepsis therapy. Reprogramming of the immune response].
    Holzmann B, Weighardt H, Heidecke CD.
    Chirurg; 2003 Jan 06; 74(1):61-4. PubMed ID: 12552407
    [Abstract] [Full Text] [Related]

  • 20. Toll-like receptor control of the adaptive immune responses.
    Iwasaki A, Medzhitov R.
    Nat Immunol; 2004 Oct 06; 5(10):987-95. PubMed ID: 15454922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 104.